ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GTBP GT Biopharma Inc

2.66
-0.17 (-6.01%)
01 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
GT Biopharma Inc NASDAQ:GTBP NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.17 -6.01% 2.66 2.63 2.74 2.83 2.62 2.80 62,383 22:18:57

Additional Proxy Soliciting Materials (definitive) (defa14a)

05/05/2023 10:30pm

Edgar (US Regulatory)


 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

SCHEDULE 14A

 

Proxy Statement Pursuant to Section 14(a) of the Securities

Exchange Act of 1934

 

Filed by the registrant ☒ Filed by a Party other than the Registrant ☐

 

Check the appropriate box:

 

  Preliminary Proxy Statement Confidential, For Use
  Definitive Proxy Statement   of the Commission Only
  Definitive Additional Materials   (as permitted by Rule
  Soliciting Material under Rule 14a-12   14a-6(e)(2))

 

GT BIOPHARMA, INC.

(Name of Registrant as Specified in Its Charter)

 

 

 

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

 

No Fee Required
   
Fee paid previously with preliminary materials
   
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

 

 

 

 
 

 

 

 

 

 

 

 

1 Year GT Biopharma Chart

1 Year GT Biopharma Chart

1 Month GT Biopharma Chart

1 Month GT Biopharma Chart

Your Recent History

Delayed Upgrade Clock